Carriers of somatic ALK rearrangements do not respond adequately to EGFR TKIs despite displaying similar clinical characteristics to patients with EGFR mutations, including never exposure to smoke and adenocarcinoma histology [85]. The gene discussed is EGFR; the disease is adenocarcinoma.